Epidemiological synergy of trichomonas vaginalis and HIV in Zimbabwean and South African women

Sexually Transmitted Diseases

Volumn 37, Issue 7, 2010, Pages 460-466

  Mavedzenge, Sue Napierala ^a   Van Der Pol, Barbara ^b,c   Cheng, Helen ^d   Montgomery, Elizabeth T ^a,d   Blanchard, Kelly ^e   De Bruyn, Guy ^f   Ramjee, Gita ^g   Van Der Straten, Ariane ^d  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Marion County Health Department   (United States)

^d RTI INTERNATIONAL   (United States)

^e IBIS REPRODUCTIVE HEALTH   (United States)

^f UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^g SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; VIRUS TRANSMISSION; AIDS-RELATED OPPORTUNISTIC INFECTIONS; COMPLICATION; CONDOM; FEMALE CONTRACEPTIVE DEVICE; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; MULTICENTER STUDY; PARASITOLOGY; PATHOGENICITY; RISK FACTOR; SEXUALLY TRANSMITTED DISEASES; SOUTH AFRICA; TREATMENT OUTCOME; TRICHOMONAS VAGINITIS; UTILIZATION; VIROLOGY; YOUNG ADULT; ZIMBABWE;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CONDOMS; CONTRACEPTIVE DEVICES, FEMALE; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; RISK FACTORS; SEXUALLY TRANSMITTED DISEASES; SOUTH AFRICA; TREATMENT OUTCOME; TRICHOMONAS VAGINALIS; TRICHOMONAS VAGINITIS; VAGINAL CREAMS, FOAMS, AND JELLIES; YOUNG ADULT; ZIMBABWE;

AGENTS USED INTRAVAGINALLY;

EID: 77954047967     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e3181cfcc4b     Document Type: Article

References (47)

1. AIDS Epidemic Update: December, 2009. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS (UNAIDS); World Health Organization (WHO), 2009.
2. Dallabetta G, Neilsen G. Efforts to control sexually transmitted infections as a means to limit HIV transmission: What is the evidence? Curr Infect Dis Rep 2005; 7:79-84.
3. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: The contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999; 75:3-17.
4. Global Prevalence and Incidence of Selected Curable Sexually Transmitted Infections, Overviews and Estimates. Geneva, Switzerland: World Health Organization (WHO), 2001.
5. Petrin D, Delgaty K, Bhatt R, et al. Clinical and microbiological aspects of Trichomonas vaginalis. Clin Microbiol Rev 1998; 11:300-317.
6. Cotch MF, Pastorek JG II, Nugent RP, et al. Trichomonas vagi-nalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis 1997; 24:353-360.
7. Moodley P, Wilkinson D, Connolly C, et al. Trichomonas vagi-nalis is associated with pelvic inflammatory disease in women infected with human immunodeficiency virus. Clin Infect Dis 2002; 34:519-522.
8. Rein MF, Chapel TA. Trichomoniasis, candidiasis, and the minor venereal diseases. Clin Obstet Gynecol 1975; 18:73-88.
9. Laga M, Manoka A, Kivuvu M, et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: Results from a cohort study. AIDS 1993; 7:95-102.
10. McClelland RS, Sangare L, Hassan WM, et al. Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. J Infect Dis 2007; 195:698-702.
11. Rottingen JA, Cameron DW, Garnett GP. A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: How much really is known? Sex Transm Dis 2001; 28:579-597.
12. Van Der Pol B, Kwok C, Pierre-Louis B, et al. Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women. J Infect Dis 2008; 197:548-554.
13. Laga M, Alary M, Nzila N, et al. Condom promotion, sexually transmitted diseases treatment, and declining incidence of HIV-1 infection in female Zairian sex workers. Lancet 1994; 344:246-248.
14. Sexton J, Garnett G, Rottingen JA. Metaanalysis and metaregres-sion in interpreting study variability in the impact of sexually transmitted diseases on susceptibility to HIV infection. Sex Transm Dis 2005; 32:351-357.
15. Cameron DW, Padian NS. Sexual transmission of HIV and the epidemiology of other sexually transmitted diseases. AIDS 1990; 4(suppl 1):S99-S103.
16. Clottey C, Dallabetta G. Sexually transmitted diseases and human immunodeficiency virus. Epidemiologic synergy? Infect Dis Clin North Am 1993; 7:753-770.
17. Dickerson MC, Johnston J, Delea TE, et al. The causal role for genital ulcer disease as a risk factor for transmission of human immunodeficiency virus. An application of the Bradford Hill criteria. Sex Transm Dis 1996; 23:429-440.
18. Mertens TE, Hayes RJ, Smith PG. Epidemiological methods to study the interaction between HIV infection and other sexually transmitted diseases. AIDS 1990; 4:57-65.
19. Wasserheit JN. Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis 1992; 19:61-77.
20. Ghys PD, Diallo MO, Ettiegne-Traore V, et al. Genital ulcers associated with human immunodeficiency virus-related immuno-suppression in female sex workers in Abidjan, Ivory Coast. J Infect Dis 1995; 172:1371-1374.
21. Rugpao S, Nagachinta T, Wanapirak C, et al. Gynaecological conditions associated with HIV infection in women who are partners of HIV-positive Thai blood donors. Int J STD AIDS 1998; 9:677-682.
22. Plummer FA, Simonsen JN, Chubb H, et al. Epidemiologic evidence for the development of serovar-specific immunity after gonococcal infection. J Clin Invest 1989; 83:1472-1476.
23. Nasio JM, Nagelkerke NJ, Mwatha A, et al. Genital ulcer disease among STD clinic attenders in Nairobi: Association with HIV-1 and circumcision status. Int J STD AIDS 1996; 7:410-414.
24. Kaul R, Kimani J, Nagelkerke NJ, et al. Risk factors for genital ulcerations in Kenyan sex workers. The role of human immunodeficiency virus type 1 infection. Sex Transm Dis 1997; 24:387-392.
25. Kamali A, Nunn AJ, Mulder DW, et al. Seroprevalence and incidence of genital ulcer infections in a rural Ugandan population. Sex Transm Infect 1999; 75:98-102.
26. McFarland W, Gwanzura L, Bassett MT, et al. Prevalence and incidence of herpes simplex virus type 2 infection among male Zimbabwean factory workers. J Infect Dis 1999; 180:1459-1465.
27. McClelland RS, Lavreys L, Katingima C, et al. Contribution of HIV-1 infection to acquisition of sexually transmitted disease: A 10-year prospective study. J Infect Dis 2005; 191:333-338.
28. Cohen MS, Hoffman IF, Royce RA, et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: Implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group. Lancet 1997; 349:1868-1873.
29. Ghys PD, Fransen K, Diallo MO, et al. The associations between cervicovaginal HIV shedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Cote d'Ivoire. AIDS 1997; 11:F85-F93.
30. Hobbs MM, Kazembe P, Reed AW, et al. Trichomonas vaginalis as a cause of urethritis in Malawian men. Sex Transm Dis 1999; 26:381-387.
31. Padian NS, van der Straten A, Ramjee G, et al. Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: A randomized controlled trial. Lancet 2007; 370: 251-261.
32. Van Der Pol B, Kraft CS, Williams JA. Use of an adaptation of a commercially available PCR assay aimed at diagnosis of chla-mydia and gonorrhea to detect Trichomonas vaginalis in urogen-ital specimens. J Clin Microbiol 2006; 44:366-373.
33. Therneau TM, Grambsch PM. Modeling Survival Data: Extending the Cox Model. New York, NY: Springer, 2000.
34. Kiviat NB, Paavonen JA, Brockway J, et al. Cytologic manifestations of cervical and vaginal infections. I. Epithelial and inflammatory cellular changes. JAMA 1985; 253:989-996.
35. Levine WC, Pope V, Bhoomkar A, et al. Increase in endocervical CD4 lymphocytes among women with nonulcerative sexually transmitted diseases. J Infect Dis 1998; 177:167-174.
36. Mayta H, Gilman RH, Calderon MM, et al. 18S ribosomal DNA-based PCR for diagnosis of Trichomonas vaginalis. J Clin Mi-crobiol 2000; 38:2683-2687.
37. Sardana S, Sodhani P, Agarwal SS, et al. Epidemiologic analysis of Trichomonas vaginalis infection in inflammatory smears. Acta Cytol 1994; 38:693-697.
38. Fouts AC, Kraus SJ. Trichomonas vaginalis: Reevaluation of its clinical presentation and laboratory diagnosis. J Infect Dis 1980; 141:137-143.
39. Shafir SC, Sorvillo FJ, Smith L. Current issues and considerations regarding trichomoniasis and human immunodeficiency virus in African-Americans. Clin Microbiol Rev 2009; 22:37-45.
40. Draper D, Donohoe W, Mortimer L, et al. Cysteine proteases of Trichomonas vaginalis degrade secretory leukocyte protease inhibitor. J Infect Dis 1998; 178:815-819.
41. Korenromp EL, White RG, Orroth KK, et al. Determinants of the impact of sexually transmitted infection treatment on prevention of HIV infection: A synthesis of evidence from the Mwanza, Rakai, and Masaka intervention trials. J Infect Dis 2005; 191(suppl 1):S168-S178.
42. Gray RH, Wawer MJ, Brookmeyer R, et al. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 2001; 357:1149-1153.
43. Varghese B, Maher JE, Peterman TA, et al. Reducing the risk of sexual HIV transmission: Quantifying the per-act risk for HIV on the basis of choice of partner, sex act, and condom use. Sex Transm Dis 2002; 29:38-43.
44. Boily MC, Baggaley RF, Wang L, et al. Heterosexual risk of HIV-1 infection per sexual act: Systematic review and meta-analysis of observational studies. Lancet Infect Dis 2009; 9:118-129.
45. Corbett EL, Steketee RW, ter Kuile FO, et al. HIV-1/AIDS and the control of other infectious diseases in Africa. Lancet 2002; 359:2177-2187.
46. Kaul R, Makadzange T, Rowland-Jones S. AIDS in Africa: A disaster no longer waiting to happen. Nat Immunol 2000; 1:267-270.
47. Mostad SB, Overbaugh J, DeVange DM, et al. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. Lancet 1997; 350:922-927.